Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Gut|February 24, 2022
Inflamed and non-inflamed classes of HCC: a revised immunogenomic classificationCarla Montironi, Florian Castet, Philipp K Haber, et al.
Journal for Immunotherapy of Cancer|March 9, 2026
First-in-human phase 1 study of RO7119929, an oral TLR7 agonist prodrug, in patients with advanced primary or metastatic liver cancersChanghoon Yoo, Carles Fabregat-Franco, Chia-Chi Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2022
Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug EvaluationQueralt Serra-Camprubí, Helena Verdaguer, Winona Oliveros, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2026
Evolving landscape of targeted therapies in early phase clinical trialsAlice Rossi, Irene Braña, Maria Vieito, et al.
Gastroenterology|September 15, 2022
Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular CarcinomaPhilipp K Haber, Florian Castet, Miguel Torres-Martin, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2024
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide populationMargherita Rimini, Lorenzo Fornaro, Mario Domenico Rizzato, et al.
The Oncologist|October 19, 2024
Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide populationFederica Lo Prinzi, Francesca Salani, Margherita Rimini, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 12, 2025
Durvalumab in Advanced Biliary Tract Cancer: Real-World Data From a Large Cohort of Patients Across Multiple International CentersMargherita Rimini, Lorenzo Fornaro, Masafumi Ikeda, et al.
Oncology|August 15, 2025
Impact of antibiotic therapy in patients with cholangiocarcinoma treated with chemoimmunotherapyFrancesco Vitiello, Caterina Vivaldi, Mario Domenico Rizzato, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 17, 2025
A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC-D IndexMara Persano, Margherita Rimini, Francesca Salani, et al.
Pageof 4